BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new ...

August 30, 2021 | News

Elekta to address Indonesia's cancer care gap with direct presence

Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...

August 25, 2021 | News

Argon Announces the Commercial Launch of the SKATER™

The SKATER™ Mini-Loop is a drainage catheter placed through the skin using imaging guidance as a minimally invasive way to remove or drain an unwante...

August 23, 2021 | News

Technology Investments will Help Oncology Practices Succeed in Value-based Care

Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services (CMS) prepares t...

August 12, 2021 | News

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody

The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...

August 10, 2021 | News

Australia Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster

Growing concern among Australian cancer organisations that ongoing COVID-19 lockdowns, and delays in routine procedures are causing cancer 'symptom ...

August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

August 06, 2021 | News

Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China

111, Inc. , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in&nb...

August 04, 2021 | News

FDA Clears Promega OncoMate™ MSI Dx Analysis System

Microsatellite instability (MSI) is a form of genomic instability caused when too many or too few repeating bases, called microsatellites, occur during DNA...

July 30, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

Zhongchao To Promote the Equalization of Breast Cancer Diagnosis

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...

July 28, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

July 26, 2021 | News

Elekta Unity to advance precision radiation medicine

Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine Elekta (EKTA-B.ST) today announced the prese...

July 23, 2021 | News

Stimulating blood vessel formation with magnets

Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. Th...

July 22, 2021 | News

Stay Connected